Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

An Inventory of Short Term and Long Term Changes in Gene Expression Under Interferon β Treatment of Relapsing Remitting MS Patients.
RORγt(+) cells selectively express redundant cation channels linked to the Golgi apparatus.
Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness.
Liver X receptors alpha and beta promote myelination and remyelination in the cerebellum.
Delayed onset adenosine deaminase deficiency associated with acute disseminated encephalomyelitis.
Vitamin D3 Receptor ( VDR ) Gene rs2228570 (Fok1) and rs731236 (Taq1) Variants Are Not Associated with the Risk for Multiple Sclerosis: Results of a New Study and a Meta-Analysis.
A molecular link between the active component of marijuana and Alzheimer's disease pathology.
Unprovoked seizures in multiple sclerosis and systemic lupus erythematosus: A population-based case-control study.
Azathioprine versus Beta Interferons for Relapsing-Remitting Multiple Sclerosis: A Multicentre Randomized Non-Inferiority Trial.
Comprehending the inexplicable: qualitative accounts of black Caribbean and white british people severely affected by multiple sclerosis.
B-07The Cognitive Health Questionnaire: Initial Psychometric Data in a Multisite Multiple Sclerosis Sample.
Effect of treatment with interferon beta-1a on changes in voxel-wise magnetization transfer ratio in normal appearing brain tissue and lesions of patients with relapsing-remitting multiple sclerosis: a 24-week, controlled pilot study.
Effects of exercise on fitness and cognition in progressive MS: a randomized, controlled pilot trial.
Patient Perspectives and Experience with Dalfampridine Treatment in Multiple Sclerosis-Related Walking Impairment: The Step Together Program.
Detection of MicroRNAs in Microglia by Real-time PCR in Normal CNS and During Neuroinflammation.
Neuronal NF-κB ablation does not influence neuro-axonal degeneration in experimental autoimmune demyelination.
Improved self-efficacy in persons with relapsing remitting multiple sclerosis after an intensive social cognitive wellness program with participation of support partners: a 6-months observational study.
Phenytoin for neuroprotection in patients with acute optic neuritis: a randomised, placebo-controlled, phase 2 trial.
Materials for stem cell factories of the future.
Age-dependent effects on the treatment response of natalizumab in MS patients.
Receptos begins enrollment of Phase 3 trial of RPC1063 in relapsing multiple sclerosis
Clinical effects of natalizumab on multiple sclerosis appear early in treatment course.
Guidelines for the use of intravenous immunoglobulin in the treatment of neurologic diseases.
Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial.
CHMP recommends granting a marketing authorization for Santhera's Raxone® for the treatment of Leber's Hereditary Optic Neuropathy (LHON)

Pages